BioSpace News Archive

10 Productivity Apps to Boost Workplace Productivity

Here is a roundup of some of the best, most useful productivity apps. They will increase your productivity levels, help you to work “smarter” and more efficiently.

March 29, 2018
·
3 min read
Deals

Analysts Question Takeda-Shire Deal, Speculate on Bidding War

Yesterday’s news that Takeda Pharmaceuticals was considering acquiring Shire is raising the possibility of a bidding war. But it’s also having decidedly different effects on the two companies’ stock prices.

March 29, 2018
·
3 min read
·
Mark Terry
Business

Unum Captures Nearly $70 Million in IPO

In an initial public offering, Unum Therapeutics snagged nearly $70 million to fund its antibody-coupled T-cell receptor technology.

March 29, 2018
·
2 min read
·
Alex Keown
Policy

Lawsuits Allege Safety Concern Over Novartis CML Drug Tasigna

A Novartis leukemia drug continues to be the subject of a handful of lawsuits filed by plaintiffs due to concerns over atherosclerosis-related conditions.

March 29, 2018
·
2 min read
·
Alex Keown
Business

MediciNova’s Drug Flunks Phase II Trial

MediciNova announced that its Phase II clinical trial of ibudilast (MN-166) failed to meet its primary endpoint for methamphetamine dependence.

March 29, 2018
·
2 min read
·
Mark Terry
Drug Development

Heron Seeks Sale of Common Stock to Fund Potential Drug Launch

Heron Therapeutics is looking to raise money to fund a potential launch of its anesthetic for bunionectomy and hernia repair by selling six million shares of its common stock.

March 29, 2018
·
2 min read
·
Alex Keown
Business

ABIVAX 2017 Full-Year Results and Progress Report

Reinforced cash position finances operations through key clinical milestones to mid-2019, phase IIb clinical programs for ABX464 in HIV and IBD patients expected to be initiated around end of 2018.

March 29, 2018
·
17 min read
Drug Development

RedX Pharma Cancer Trial Paused: Serious Side Effects

Redx Pharma dosed its first patient for the Porcupine inhibitor RXC004 on February 6. The company indicates it has paused the trial after the first patient dosed had “clinically significant” adverse events.

March 29, 2018
·
2 min read
·
Mark Terry
Trend Alert: Pharma Increases Funding for Outside Innovation

According to HBM Partners, a healthcare investing firm, out of the drugs approved over the last five years, 63 percent originated at smaller companies.

March 29, 2018
·
3 min read
·
Mark Terry
Biotech Bay

Hyundai Hope On Wheels Surpasses $145 Million To Research Celebrating Its 20th Year In The Fight To End Childhood Cancer

The organization announces $15 million in new grant winners at the New York International Auto Show as part of Hyundai’s longstanding support to pediatric cancer.

March 29, 2018
·
9 min read